Physician profile
Daniel B Gordon
NPI 1790824944
$1,062.42
in general payments reported to CMS, 2019-2025
14 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $121 · 2021: $13.94 · 2022: $70.12 · 2023: $373 · 2024: $192 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332 · Gift: $274 · Education: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.32 |
| Gift | $273.99 |
| Education | $148.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $273.99 | 2023 | Opalescence |
| Align Technology, INC. | $178.52 | 2020-2025 | Invisalign |
| Hu-Friedy Mfg. Co., LLC | $148.25 | 2025 | |
| Biohorizons Implant Systems INC. | $146.56 | 2021-2024 | Biohorizons |
| Henry Schein, INC. | $65.48 | 2019-2023 | 3shape Trios A/S-Trios3 Mc Pod-Pen(Redu) |
| Straumann USA LLC | $61.70 | 2019 | |
| Dentsply Sirona INC | $54.40 | 2024 | Cavitron, Midwest E Plus |
| Zimvie INC. | $28.30 | 2023 | |
| Nobel Biocare USA | $25.56 | 2019 | |
| Solventum Corporation | $19.58 | 2024 | 3m Scotchbond |
| Colgate Oral Pharmaceuticals, INC. | $17.38 | 2025 | |
| Air Techniques, INC. | $16.95 | 2022 | |
| Philips North America LLC | $14.76 | 2023 | |
| Gc America INC. | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.